AzTrials
AzTrials

Weaning Mechanical VentilationWeaning-POPNCT07786519

Airway Occlusion Pressure Derived Parameters During Spotaneous Breathing Trial for Predicting Extubation Failure

An observational study of Weaning Mechanical Ventilation, run by Rennes University Hospital at 4 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Weaning from invasive mechanical ventilation (IMV) is a critical stage of the intensive care unit (ICU) stay. Premature IMV discontinuation may expose patients to substantial cardiopulmonary stress, whereas prolonged weaning increases exposure to complications associated with IMV, including ventilator-associated… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Weaning Mechanical Ventilation
How many people
225 participants
Where
4 sitesFrance
Study dates
17 Apr 2024to 3 Sep 2025
How long will I take part?
40 Days
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The study was conducted in four critical care units in the Brittany region of France over a 12-month period, using the ventilators available at each center without specific selection, to best reflect usual clinical practices: a tertiary academic surgical ICU at Rennes University Hospital (30 beds) and three general ICUs at Saint-Brieuc Hospital (21 beds), Saint-Malo Hospital (15 beds), and Vannes Hospital (20 beds).

Who may be able to join

  • Adult patients meeting all the weaning criteria set out in the consensus of the International Conference on Weaning:
  • Duration of mechanical ventilation prior to the first weaning trial > 24 hours
  • Respiratory rate ≤ 35 breaths/min,
  • Adequate oxygenation defined as SpO₂ ≥ 90% with FiO₂ ≤ 0.4 or PaO₂/FiO₂ ≥ 150 mm Hg with PEEP ≤ 8 cmH₂O,
  • Adequate cough reflex,
  • A conscious patient who is responsive to commands and has a RASS (Richmond Agitation Sedation Scale) score between +1 and -2
  • Haemodynamically stable without vasopressors or on a minimal dose (noradrenaline <0.1 µg/kg/min)
  • Patient informed about the study and expressing no objection to participating

Who cannot join

  • Patients with neurological injury and a Glasgow Motor Score of ≤ M5
  • Decision not to reintubate in the event of extubation failure
  • Adults subject to legal protection (judicial protection, curatorship, guardianship), and persons deprived of their liberty

Trial locations and contacts

4 sites in 1 country.

France4 sites
  • CHU de Rennes

    Rennes

  • Centre hospitalier de Saint Brieuc

    Saint-Brieuc

  • Centre hospitalier de Saint Malo

    St-Malo

  • Centre Hospitalier Bretagne Atlantique

    Vannes

Other trials in France

About this study

Official title: The Predictive Value of Airway Occlusion Pressure Derived Parameters During Spontaneous Breathing Trial on Successful Weaning From Mechanical Ventilation

Weaning from invasive mechanical ventilation (IMV) is a critical stage of the intensive care unit (ICU) stay. Premature IMV discontinuation may expose patients to substantial cardiopulmonary stress, whereas prolonged weaning increases exposure to complications associated with IMV, including ventilator-associated pneumonia (VAP), diaphragmatic muscle atrophy, and barotrauma.

Extubation failure, defined as the need for reintubation within 48-72 h after extubation, occurs in approximately 10-15% of patients reaching 20% in high-risk patients including factors of age >65 years, chronic cardiac or respiratory disease, IMV duration >7 days. Extubation failure is associated with substantial morbidity and mortality, with reported hospital mortality rates up to 25-50%, as well as prolonged ICU length of stay and increased healthcare costs.

Read more

Modern ventilators provide simple, non-invasive access to two complementary physiological indices: the airway occlusion pressure at 100 ms (P0.1), a surrogate of central respiratory drive, and the change in inspiratory pressure during an occlusion maneuver (ΔPocc), a marker of the overall inspiratory effort.

This study assesses the predictive value of P0.1 and ΔPocc measured before and during an SBT for predicting reintubation within 3 days after extubation.

Keywords
ICU, MEchanical ventilation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07786519
Study groupRoleWhat they receive
Patients with mechanical ventilation elligible for weaningConducting a systematic measurement of respiratory effort markers during a weaning trial with inspiratory support during the stay in ICU

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Reintubation rate within 3 days after extubation

    Number of patients requiring reintubation within 3 days following extubation

    Measured: 3 days following extubation

Secondary outcomes (5)
  1. Reintubation rate within 2 days after extubation

    Number of patients requiring reintubation within 2 days following extubation

    Measured: 2 days following extubation

  2. Reintubation rate within 7 days after extubation

    Number of patients requiring reintubation within 7 days following extubation

    Measured: 7 days following extubation

  3. ICU mortality

    Number of patients who died during the stay in ICU

    Measured: From ICU admission to ICU discharge or death, assessed up to 60 days

  4. ICU length of stay

    the length of time between admission to and discharge from the intensive care unit

    Measured: Between admission to and discharge from the ICU, assessed up to 60 days

  5. Hospital length of stay

    The length of time between admission to the ICU and discharge from the hospital

    Measured: From ICU admission to hospital discharge, assessed up to 90 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Aug 2026
  2. Study start17 Apr 2024
  3. Primary completion17 Apr 2025
  4. Study completion3 Sep 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
225 participants (actual)
Target duration
40 Days
IDs, dates and publications
ClinicalTrials.gov ID
NCT07786519
Sponsor's protocol ID
35RC23_9774_04
Acronym
Weaning-POP
Status last verified
Aug 2026
First submitted
21 Aug 2026
Last updated
26 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
Individual data sharing
Yes: All individual participant data collected during the trial may be made available, following the initial publication of the results, to any researchers who submit a methodologically sound proposal. Proposals must be submitted to the study contact point. To gain access to the data, applicants will be required to sign a data access agreement; additional formalities may be required, as appropriate.

Questions about this trial

What is this clinical trial studying?

An observational study of Weaning Mechanical Ventilation, run by Rennes University Hospital at 4 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Reintubation rate within 3 days after extubation (time frame: 3 days following extubation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in